Literature DB >> 32069163

Association Between the Serum Uric Acid Level and the Severity of Coronary Artery Disease in a Retrospective Study of China Nondialysis CKD Patients.

Yan Yang1, Li-Hua Lin2, Min Gao1, Ri-Ning Tang1, Kun-Ling Ma1, Yan Tu1, Hong Liu1, Bi-Cheng Liu1.   

Abstract

Introduction: Hyperuricemia has been associated with increased cardiovascular events in the general population. However, the role of serum uric acid (SUA) level on the severity of coronary artery stenosis (CAS) in nondialysis chronic kidney disease (CKD) patients is obscure.
Methods: We implement a retrospective cohort study of 734 patients diagnosed with stage 3-5 CKD. All selected patients underwent coronary artery angiography. The associations of SUA with the present, and severity of coronary artery disease (CAD) were analyzed.
Results: Of these 734 patients, 511 patients had angiographically proven CAD. Compared with non-CAD group, the SUA level in CAD group was much higher (388.00 vs. 363.00 μmol/l, P < 0.01). After adjusting for multiple confounding factors, a multivariate logistic regression analysis demonstrated that SUA was relevant to the presence of CAD when SUA as a continuous variable. However, this relationship was not observed with SUA as a categorical variable. In a subgroup analysis for the CAD group, we found that the rates of severe CAS in the third tertile of SUA (58.6%) was higher than that in the first tertile (41.6%) (P < 0.01). Compared with the first tertile of SUA, the third tertile of SUA was an independent risk factor for severe arterial stenosis (odds ratio, OR, 1.976 [1.203-3.248]), a pattern that was recapitulated by multivariate logistic regression analysis with SUA as a continuous variable (1.002 [1.000-1.004]). Conclusions: The SUA level may serve as a predictor of the severity of CAS among nondialysis CKD patients with CAD.

Entities:  

Keywords:  coronary artery disease; coronary artery stenosis; gensini score system; serum uric acid; stage 3–5 chronic kidney disease

Mesh:

Substances:

Year:  2020        PMID: 32069163     DOI: 10.1089/met.2019.0114

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  2 in total

1.  The Impact of an Elevated Uric Acid Level on the Prevalence of Coronary Artery Disease in Pancreas Transplant Candidates with Type 1 Diabetes: A Cross Sectional Study.

Authors:  Małgorzata Buksińska-Lisik; Przemysław Kwasiborski; Robert Ryczek; Wojciech Lisik; Artur Mamcarz
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

2.  Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease.

Authors:  Zixiang Ye; Yaxin Wu; Yimin Tu; Mulei Chen; Yanxiang Gao; Linying Shi; Peizhao Li; Enmin Xie; Ziyu Guo; Qing Li; Xiaozhai Yu; Yike Li; Wenquan Niu; Jingyi Ren; Jingang Zheng
Journal:  Front Cardiovasc Med       Date:  2022-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.